26 S proteasome-mediated degradation of topoisomerase II cleavable complexes. - Wikidata - wikimedia - TriplyDB

26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.

26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.

http://www.wikidata.org/entity/Q43730370

about

Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: Implications in infant leukemia Targeting DNA topoisomerase II in cancer chemotherapy Collision of Trapped Topoisomerase 2 with Transcription and Replication: Generation and Repair of DNA Double-Strand Breaks with 5' Adducts Mechanism of repair of 5′-topoisomerase II–DNA adducts by mammalian tyrosyl-DNA phosphodiesterase 2 Proteolytic Degradation of Topoisomerase II (Top2) Enables the Processing of Top2{middle dot}DNA and Top2{middle dot}RNA Covalent Complexes by Tyrosyl-DNA-Phosphodiesterase 2 (TDP2)Processing of damaged DNA ends for double-strand break repair in mammalian cells The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target Topoisomerase II-mediated DNA damage is differently repaired during the cell cycle by non-homologous end joining and homologous recombination Numerical analysis of etoposide induced DNA breaks Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta Replication-dependent and transcription-dependent mechanisms of DNA double-strand break induction by the topoisomerase 2-targeting drug etoposide The SUMO pathway is required for selective degradation of DNA topoisomerase IIbeta induced by a catalytic inhibitor ICRF-193(1)Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling Nonhomologous end joining: a good solution for bad ends Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).Tdp2: a means to fixing the ends Transcription-dependent degradation of topoisomerase I-DNA covalent complexes The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway All tangled up: how cells direct, manage and exploit topoisomerase function.Prognostic values of filamin-A status for topoisomerase II poison chemotherapy Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.Nurr1 regulates Top IIβ and functions in axon genesis of mesencephalic dopaminergic neurons Detection of DNA-protein crosslinks (DPCs) by novel direct fluorescence labeling methods: distinct stabilities of aldehyde and radiation-induced DPCs.MRE11 facilitates the removal of human topoisomerase II complexes from genomic DNA.DNA double-strand breaks with 5' adducts are efficiently channeled to the DNA2-mediated resection pathway.Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.MRN, CtIP, and BRCA1 mediate repair of topoisomerase II-DNA adducts.Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity of the enzyme: Identification based on artifactual +80-Da modification at this site The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells.SUMO modification of DNA topoisomerase II: trying to get a CENse of it all Activation of a novel ubiquitin-independent proteasome pathway when RNA polymerase II encounters a protein roadblock.Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks.Chemistry and biology of DNA containing 1,N(2)-deoxyguanosine adducts of the alpha,beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal.Novel TDP2-ubiquitin interactions and their importance for the repair of topoisomerase II-mediated DNA damage.The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 2: transcriptional regulation Repair of hydantoin lesions and their amine adducts in DNA by base and nucleotide excision repair.Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents.Interaction between glucose-regulated destruction domain of DNA topoisomerase IIalpha and MPN domain of Jab1/CSN5.Mutagenic potential of DNA-peptide crosslinks mediated by acrolein-derived DNA adducts

P2860

Q24603077-FF082BEB-F04C-47E1-A697-8A481D3AD426 Q24649711-87FDFEE9-2FBB-4E57-8C98-8ED1DEA2F5E3 Q26744712-6A85E2C8-F671-46B0-A126-D49FC21843AB Q27674755-5750F44E-1B98-4CFB-B645-66258205C84C Q27683681-324B4EDA-A45A-4100-B9D6-346DD1DBF826 Q28000148-EF6C2510-CAAC-47B4-B97D-6F0B40F5EB9B Q28472102-7BF22327-12D7-4F7C-A254-06477ACA669C Q28475376-BE59135F-30D2-4545-BB5F-88F8309124FB Q28475598-41C4D81B-6EDB-4489-B6A5-949B7F0CF0E1 Q28509730-EC269F9D-20DA-4249-A691-3C88991FF92A Q28534943-2A3DDC86-52C5-4E6A-9DEC-46F25632CFBD Q28609928-3EB18940-081B-4214-AF30-70D3F14AB74C Q30496293-95C69D67-B4B7-4321-A8DC-4031C36BD9C1 Q33625010-CD3F83D1-FF29-44E4-AED3-75D19D21C56D Q33875792-55169313-81D0-4A67-9E10-995EBD5C728A Q34625433-0D77511B-048B-4B27-AE2A-C2D9EE17A4BE Q34784817-AA6D077C-6E9D-4256-80F5-60686A5897EB Q34868039-49B6C06F-F0F0-4E3B-AF15-CDDCC0B69F03 Q35154537-6AAC21E9-5017-4EEE-B464-A0A24A382EF7 Q35828535-7B28A361-B633-4832-B75F-858943EE1BD1 Q35865072-0400D233-640D-41EE-B5C2-EC364D719001 Q35984215-F6167353-2678-464B-995F-CF7AFD847197 Q36305588-4086C1DD-3443-4DB9-A1F9-39870E1322C6 Q36425680-82CC1C69-5E85-4330-94D9-46BECABE2DF3 Q36443382-19DDE39D-4411-432F-BBC1-F22CDC335DAF Q36568915-09FC5F03-72F3-4E7B-8CF1-24D89E76DBEE Q36583279-7354D4B7-5086-4BA0-8E35-63903D99AD80 Q36716126-98E5981D-E3EA-4414-BA48-8BFDB1F93922 Q37061217-DDB77B28-D072-463D-831B-12749195E097 Q37148274-6F6D62C5-4231-44B9-B86D-81102CF6C886 Q37207512-C274E355-A75F-4EF3-96F9-F556007E0E20 Q37264391-CC726992-D425-41DA-A253-9C8AD213C64E Q37459929-23C3F284-EF43-4B38-8647-B7E6309252BC Q37461336-7733F726-27E8-43AA-AD2D-2FB2ACDDD98D Q37472973-4CF959C8-793E-4F0A-A94A-4DBD426731B1 Q37517720-A913D683-84BC-450D-94A2-6EDBB306A970 Q37532110-3ECA7AF9-6D75-4F5D-B362-92ACB452CC41 Q38029323-AE7FC961-A4A0-4DE2-99E4-1A03E515067F Q38341652-90A4F7C5-EDF8-4A64-AAD4-5C3CFF21179B Q38573535-D976C40C-E2EB-4A25-9DFD-28FBF1B0701D

P2860

26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.

http://www.wikidata.org/entity/Q43730370

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.

@en

26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.

@nl

type

label

26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.

@en

26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.

@nl

prefLabel

26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.

@en

26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.

@nl

P1433

Q43730370-A3A4DC29-9684-4701-915F-EE9A43850F72

P1476

Q43730370-1116E8BE-8C4D-4BE4-B66C-0A319515E2F9

P2093

Q43730370-161A492A-AEB4-4B20-9091-CEAF66B14E77

Q43730370-210C3BD5-DC9E-45A3-B018-269A98CB83CF

Q43730370-3248B2D7-CB39-4438-A83B-BE8AC8909DE6

Q43730370-70EC0973-723D-49D7-9E0F-76DE1E44792B

P2860

Q43730370-044C02DE-B08B-4D00-AADF-D944D777F413

Q43730370-0C57F6E5-29DD-4A1A-A6FB-0F4483E9548A

Q43730370-13298456-9B81-492E-BEAF-9202A6497C75

Q43730370-1A445D13-049E-4841-BC42-6CF2E8F0180A

Q43730370-1EA2C556-38DC-48A2-8063-0E34489C94BB

Q43730370-23041837-2FD5-4F17-AA64-1806DD035360

Q43730370-25C0FE79-3915-4963-B3FB-3C9162B2F1ED

Q43730370-2AA5128B-9D78-46C1-ADC3-8F033116ADCE

Q43730370-2B1F09C1-F56B-4350-AC28-3959DABF2A14

Q43730370-2C7BA4CE-E020-453A-A515-CA4E27347AD1

P304

Q43730370-9763329F-9AD8-4E0E-B199-97613DB545E2

P31

Q43730370-C5411802-F8CE-4912-9C36-1F266F15DFE0

P356

Q43730370-A494DAC3-B789-487B-9DFE-F410511E6183

P407

Q43730370-AE726FE2-7FE8-40EA-A770-21FAC5AAC29F

P433

Q43730370-D832F596-3630-4689-944F-044B4826C817

P478

Q43730370-145141B0-A868-4337-8346-A027EB7B9035

P50

Q43730370-608A70B6-31F9-4D68-BD8E-8473AB9FD3A5

P577

Q43730370-A76D5A48-3D8B-4C13-B40F-1FCF1A7889DF

P698

Q43730370-6F14CD1B-CD6C-4865-9CF8-7C798AB68B87

P356

P1433

Journal of Biological Chemistry

P1476

26 S proteasome-mediated degradation of topoisomerase II cleavable complexes

@en

P2093

Desai SD

http://www.w3.org/2001/XMLSchema#string

Hwang J

http://www.w3.org/2001/XMLSchema#string

Mao Y

http://www.w3.org/2001/XMLSchema#string

Ting CY

http://www.w3.org/2001/XMLSchema#string

P2860

Human TOP3: a single-copy gene encoding DNA topoisomerase III

A new human topoisomerase III that interacts with SGS1 protein

Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes

Isolation of cDNA clones encoding the beta isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24

Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia

SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage

SUMO-1 conjugation to human DNA topoisomerase II isozymes

Chromosomal stability and the DNA double-stranded break connection

Immunohistochemical analyses of DNA topoisomerase II isoforms in developing rat cerebellum

DNA topoisomerase IIbeta and neural development

P304

40652-40658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M104009200

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

276

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11546768

http://www.w3.org/2001/XMLSchema#string